Treatment of pediatric patients (pts) with relapsed/refractory B-cell acute lymphoblastic leukemia (R/R B-ALL) with obecabtagene autoleucel (obe-cel), a CD19-directed chimeric antigen receptor (CAR) T-cell therapy: Preliminary findings from the Phase Ib/II CATULUS trial
Year: 2025
Type: conference-abstract
Source: Blood
Institutions: Great Ormond Street Hospital, Great Ormond Street Hospital for Children NHS Foundation Trust, Primary Children's Hospital, University of Utah, Huntsman Cancer Institute, Hospital Infantil Universitario Niño Jesús, Methodist Children’s Hospital, St Mary's Hospital, Royal Manchester Children's Hospital, Vall d'Hebron Institut de Recerca, Vall d'Hebron Hospital Universitari, Great North Children's Hospital, Autolus (United Kingdom), Children's Hospital of Philadelphia
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4417004005
Cites:
Cited by:
Related to: